September 2006. Volume 2. Number 3

Single dose of anti-D immune globulin is as effective as intravenous immune globulin at rapidly raising the platelet count in the treatment of immune thrombocytopenic purpura in children

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, et al for the Acute ITP Study Group. Single dose of anti-D inmune globulin at 75µg/kg is as effective as intravenous inmune globulin at rapidly raising the platelet count in newly diagnosed inmune thrombocytopenic purpura in children. J Pediatr. 2006;148:489-94
Reviewers: Cuervo Valdés JJ1, Carreazo Pariasca NY2.
1CS Ciudad Jardín. Badajoz. España.
2Hospital de Emergencias Pediátricas. Lima. Perú.
Correspondence: Jaime Javier Cuervo Valdés. Email: jaimejcv@gmail.com
Reception date: 21/07/2006
Acceptance date: 29/07/2006
Publication date: 01/09/2006

Abstract

How to cite this article

Cuervo JJ, Carreazo NY. Una dosis única de gammaglobulina antiD es al menos tan eficaz como la inmunoglobulina intravenosa para el tratamiento de la púrpura trombocitopénica idiopática. Evid Pediatr. 2006;2:57.

AVC | Critically appraised articles

Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, et al for the Acute ITP Study Group. Single dose of anti-D inmune globulin at 75µg/kg is as effective as intravenous inmune globulin at rapidly raising the platelet count in newly diagnosed inmune thrombocytopenic purpura in children. J Pediatr. 2006;148:489-94
Reviewers: Cuervo Valdés JJ1, Carreazo Pariasca NY2.
1CS Ciudad Jardín. Badajoz. España.
2Hospital de Emergencias Pediátricas. Lima. Perú.
Correspondence: Jaime Javier Cuervo Valdés. Email: jaimejcv@gmail.com
Reception date: 21/07/2006
Acceptance date: 29/07/2006
Publication date: 01/09/2006

How to cite this article

Cuervo JJ, Carreazo NY. Una dosis única de gammaglobulina antiD es al menos tan eficaz como la inmunoglobulina intravenosa para el tratamiento de la púrpura trombocitopénica idiopática. Evid Pediatr. 2006;2:57.

References

  1. Semple JW, Allen D, Rutherford M, Woloski M, David M, Wakefield C et al. Anti D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production. Am J Hematol. 2002;69:225-7.
  2. El Alfy M, Mokhtar G, El Laboudy M, Khalifa A. Randomized trial of anti D immunoglobulin versus low dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. Acta Haematol. 2006;115:46-52.
  3. Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, et al. Intravenous anti-D treatment of inmune thrombocytopenic purpura: experience in 272 patients. Blood. 1997;89:2689-700.
  4. Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.. J Pediatr. 1999;134:21-6.
  5. British Committee for Standards in Haematology General Haematology Task Force . Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574–96.
01/09/2006

Linked Comment